TNFRSF4 and autoimmune disease: Some studies have shown that in vivo blockade of OX40 signaling specifically suppresses the function of recently activated autoantigen-specific T cells, resulting in inhibition of autoimmune disease without severe immunosuppression (Li et al. 2007; Malmstrom et al. 2001; Nohara et al. 2001).